ABCL logo

AbCellera Biologics Inc. (ABCL) Free cash flow

annual FCF:

-$186.95M-$65.57M(-54.02%)
December 31, 2024

Summary

  • As of today (July 26, 2025), ABCL annual free cash flow is -$186.95 million, with the most recent change of -$65.57 million (-54.02%) on December 31, 2024.
  • During the last 3 years, ABCL annual FCF has fallen by -$373.08 million (-200.44%).
  • ABCL annual FCF is now -191.33% below its all-time high of $204.70 million, reached on December 31, 2022.

Performance

ABCL Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

quarterly FCF:

-$22.19M+$1.44M(+6.09%)
March 31, 2025

Summary

  • As of today (July 26, 2025), ABCL quarterly free cash flow is -$22.19 million, with the most recent change of +$1.44 million (+6.09%) on March 31, 2025.
  • Over the past year, ABCL quarterly FCF has increased by +$43.66 million (+66.30%).
  • ABCL quarterly FCF is now -109.18% below its all-time high of $241.69 million, reached on June 30, 2022.

Performance

ABCL quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

TTM FCF:

-$143.29M+$43.66M(+23.35%)
March 31, 2025

Summary

  • As of today (July 26, 2025), ABCL TTM free cash flow is -$143.29 million, with the most recent change of +$43.66 million (+23.35%) on March 31, 2025.
  • Over the past year, ABCL TTM FCF has dropped by -$15.11 million (-11.79%).
  • ABCL TTM FCF is now -149.97% below its all-time high of $286.77 million, reached on June 30, 2022.

Performance

ABCL TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

ABCL Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-54.0%+66.3%-11.8%
3 y3 years-200.4%-125.9%-186.3%
5 y5 years-10000.0%-249.6%-999.7%

ABCL Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-191.3%at low-109.2%+84.3%-150.0%+27.6%
5 y5-year-191.3%at low-109.2%+84.3%-150.0%+27.6%
alltimeall time-191.3%at low-109.2%+84.3%-150.0%+27.6%

ABCL Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$22.19M(-6.1%)
-$143.29M(-23.4%)
Dec 2024
-$186.95M(+54.0%)
-$23.63M(-50.1%)
-$186.95M(-5.5%)
Sep 2024
-
-$47.40M(-5.3%)
-$197.92M(+15.8%)
Jun 2024
-
-$50.08M(-24.0%)
-$170.96M(+33.4%)
Mar 2024
-
-$65.85M(+90.3%)
-$128.19M(+5.6%)
Dec 2023
-$121.38M(-159.3%)
-$34.60M(+69.3%)
-$121.38M(+78.0%)
Sep 2023
-
-$20.44M(+180.0%)
-$68.20M(-63.9%)
Jun 2023
-
-$7.30M(-87.6%)
-$189.06M(-415.5%)
Mar 2023
-
-$59.05M(-417.8%)
$59.93M(-70.7%)
Dec 2022
$204.70M
$18.58M(-113.2%)
$204.70M(+28.0%)
Sep 2022
-
-$141.30M(-158.5%)
$159.98M(-44.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
$241.69M(+181.9%)
$286.77M(+72.8%)
Mar 2022
-
$85.72M(-427.9%)
$165.96M(-10.8%)
Dec 2021
$186.13M(+2221.7%)
-$26.14M(+80.2%)
$186.13M(-12.2%)
Sep 2021
-
-$14.51M(-112.0%)
$212.05M(-3.1%)
Jun 2021
-
$120.88M(+14.1%)
$218.87M(+82.0%)
Mar 2021
-
$105.90M(<-9900.0%)
$120.27M(+1400.1%)
Dec 2020
$8.02M(-715.3%)
-$224.00K(-97.1%)
$8.02M(-2.7%)
Sep 2020
-
-$7.69M(-134.5%)
$8.24M(-48.3%)
Jun 2020
-
$22.27M(-450.9%)
$15.93M(-350.9%)
Mar 2020
-
-$6.35M
-$6.35M
Dec 2019
-$1.30M(-25.2%)
-
-
Dec 2018
-$1.74M
-
-

FAQ

  • What is AbCellera Biologics Inc. annual free cash flow?
  • What is the all time high annual FCF for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual FCF year-on-year change?
  • What is AbCellera Biologics Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly FCF year-on-year change?
  • What is AbCellera Biologics Inc. TTM free cash flow?
  • What is the all time high TTM FCF for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. TTM FCF year-on-year change?

What is AbCellera Biologics Inc. annual free cash flow?

The current annual FCF of ABCL is -$186.95M

What is the all time high annual FCF for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual free cash flow is $204.70M

What is AbCellera Biologics Inc. annual FCF year-on-year change?

Over the past year, ABCL annual free cash flow has changed by -$65.57M (-54.02%)

What is AbCellera Biologics Inc. quarterly free cash flow?

The current quarterly FCF of ABCL is -$22.19M

What is the all time high quarterly FCF for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly free cash flow is $241.69M

What is AbCellera Biologics Inc. quarterly FCF year-on-year change?

Over the past year, ABCL quarterly free cash flow has changed by +$43.66M (+66.30%)

What is AbCellera Biologics Inc. TTM free cash flow?

The current TTM FCF of ABCL is -$143.29M

What is the all time high TTM FCF for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high TTM free cash flow is $286.77M

What is AbCellera Biologics Inc. TTM FCF year-on-year change?

Over the past year, ABCL TTM free cash flow has changed by -$15.11M (-11.79%)
On this page